Directors' Profile

Male, Age 62, Malaysian

Appointed on
1 October 2024

Last re-election on
None

Skills Matrix
Human Resource
Public Administration

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Dato’ Seri Abdul Razak’s distinguished career in public service began in 1988 as a Public Relations Officer at the Seremban City Council. He joined the Administrative and Diplomatic Official (PTD) in 1991, marking the start of his impactful journey in Government. He currently holds several key directorships in public and statutory bodies, including serving as Chairman of Lintasan Resources Sdn Bhd, Chairman of Universiti Malaysia Pahang Al Sultan Abdullah (UMPSA) and its Foundation, as well as a Board Member of Perbadanan Tabung Pendidikan Tinggi Nasional (PTPTN).

From 1992 to 1996, he played a key role in national security as Assistant Director at the Federal Special Task Force in Sabah and the National Security Council under the Prime Minister’s Office. His contributions were instrumental in shaping national security strategies during a pivotal time.

In 1996, Dato’ Seri Abdul Razak transitioned to the Selangor State Government, where he held several leadership positions, including Head of Internal Audit & Public Complaints and Assistant Secretary for Services & Training. His tenure marked a significant contribution to state governance and public service delivery.

Rising through the ranks, he was appointed Director of Community Development at Petaling Jaya Municipal Council in 2002, followed by Director of Corporate Planning at Ampang Jaya Municipal Council in 2003. His leadership was further recognised in 2006 when he became Deputy President of the Sepang Municipal Council, and later, President of the Kuala Langat Municipal Council in 2009, where he led transformative municipal projects.

In 2012, Dato’ Seri Abdul Razak moved to the Unit Kerjasama Awam Swasta - UKAS, Prime Minister Department - PMD, where he held multiple strategic roles, including Director for Security, Housing, and Land Development, and played a key role in public-private partnerships. His expertise in policy, public administration, and inter-governmental coordination was invaluable.

In 2013, his career reached new heights when he was appointed Division Secretary at the Ministry of Defence (MINDEF), overseeing Finance and Procurement divisions, where his leadership enhanced financial operations and procurement strategies.

From 2015 to 2019, as Deputy Secretary General at the Ministry of Works, he shaped national infrastructure policies and strategic development. In 2019, he was appointed State Secretary for Penang, driving the state’s development agenda and improving governance efficiency.

Most recently, Dato’ Seri Abdul Razak served as Secretary General at the Ministry of Higher Education from 2021 to 2023, where he provided visionary leadership in shaping Malaysia’s higher education policies and initiatives. Throughout his illustrious career, Dato’ Seri Abdul Razak has been a driving force in public administration, governance, and national development.

Qualification(s)
• Master of Science in Human Resource Development, Universiti Putra Malaysia
• Postgraduate Diploma in Public Management, National Institute of Public Administration (INTAN)
• Bachelor of Communication (Honours), Universiti Kebangsaan Malaysia

Male, Age 53, Malaysian

Appointed on
1 March 2024 (Redesignated as Managing Director on 1 September 2024)

Last re-election on
5 June 2024

Skills Matrix
Legal & Regulatory
Corporate Planning & Development
Negotiation

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
• 400,000 ordinary shares

Directorship in other public listed companies
• PT Millennium Pharmacon International Tbk

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Dato’ Zulkifli’s career began as a legal counsel at Panglima Aces Sdn. Bhd. in 1997. Rapidly ascending the ranks, he distinguished himself as an advocate and solicitor at Messrs Raslan Loong within the same year and by 2002, Dato’ Zulkifli became a partner at Messrs Rashid Zulkifli. Beyond his legal practice, Dato’ Zulkifli serves as a director and major shareholder of MMA Resources Sdn. Bhd., an oil & gas company.

In addition to his corporate responsibilities, Dato’ Zulkifli is actively engaged in shaping the landscape of development and governance. Currently, he holds the positions of Chairman and Director at Era Universe Development Sdn. Bhd., a development company.

Dato’ Zulkifli had served as the Legal Advisor for Johor State Government Linked Companies (GLC). His diverse portfolio included directorships in esteemed organisations such as the Cooperative Commission of Malaysia, the regulator body of cooperatives in the country; Board of Trustee of the Foundation of Research and Transformation, an independent think tank research body of the Prime Minister’s Office; and Songa Offshore Malaysia Sdn. Bhd.

Internationally, Dato’ Zulkifli was a director and management member of the Chartridge Conference Centre (UK) Limited, overseeing the operations of four hotels and conference centres in the United Kingdom.

In 2020, Dato’ Zulkifli assumed the position of Chairman at ldaman Pharma Manufacturing Sdn. Bhd., a subsidiary of Pharmaniaga Berhad (Pharmaniaga) and subsequently, appointed as the Group Executive Director of Pharmaniaga in March 2022. In February 2023, he was redesignated as Deputy Chief Executive Officer of Pharmaniaga.

In January 2023, Dato’ Zulkifli was appointed as a board member of University Sains Islam Malaysia (USIM) and in June 2023, he was appointed to be the Chairman of USIM Tijarah Holdings Sdn. Bhd., the holding company of USIM. He was also appointed as the Chairman of the Advisory Panel (Faculty of Sharia and Law) and the Investment Committee.

On 1 March 2024, Dato’ Zulkifli was appointed as the Executive Director of Pharmaniaga, taking over the role and functions of the Executive Committee which was dissolved, and subsequently, he was redesignated as Managing Director on 1 September 2024.

Qualification(s)
• Master of Business Administration, MAHSA University
• Certified Patent Agent
• Advocate and Solicitor of the High Court of Malaya
• Admission to Malaysian Bar in 1996
• Bachelor of Laws (Honours), Universiti Islam Antarabangsa Malaysia

Male, Age 54, Malaysian

Appointed on
20 November 2020

Last re-election on
18 June 2025

Skills Matrix
Human Capital & Knowledge Management
Legal & Regulatory
International Affairs
Public Policy & Governance

Board Committee(s)
• Chairman of Nominating and Remuneration Committee
• Chairman of Sustainability Committee
• Member of Audit Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Dr. Abdul Razak is the Founding Director of Bait Al Amanah, a political security and international affairs think tank based in Kuala Lumpur.

He is currently the Special Advisor to the Foreign Minister of Malaysia and Malaysia’s Representative to the Advisory Board of ASEAN Institute for Peace and Reconciliation (ASEAN-IPR), Jakarta. He is also a member of the Board of Directors at Universiti Malaysia Sarawak (UNIMAS) and the Board of Governors of MAHSA University.

Dr. Abdul Razak previously served as the member of the Consultative Council on Foreign Policy, Ministry of Foreign Affairs, a senior advisor in the Ministry of Higher Education Malaysia and a consultant to the special consultancy team on globalisation at the National Economic Action Council (NEAC) of the Prime Minister’s Department.

He was also a faculty member at the National Defence University of Malaysia, teaching international security, international law and global affairs. At present, he is an Adjunct Professor in a few national and international universities.

On the international front, Dr. Abdul Razak had served as consultant and policy advisor in peace building and international development strategies in the Middle East, North Africa, ASEAN and the Southern Pacific region. He was also engaged by the European Union and the World Bank as a subject matter expert on human development and human security-related issues. Board

He is a qualified legal counsel, having trained in Malaysia and the United Kingdom (UK) and received his PhD in Law and International Security from the University of Leeds, UK. He did his fellowship at East West Centre (University of Hawaii) and was a visiting researcher at Colombia University. He also attended leadership executive programmes at Said Business School (Oxford University) and Kennedy School of Government (Harvard University).

On 22 February 2023, Dr. Abdul Razak was redesignated as Senior Independent Non-Executive Director of Pharmaniaga.

Qualification(s)
• Doctor of Philosophy in Law (International Security), University of Leeds, United Kingdom
• Master of Laws in International Trade Law, University of Kent at Canterbury, United Kingdom
• Bachelor of Laws (Honours), Universiti Islam Antarabangsa Malaysia
• Advocate and Solicitor, High Court of Sabah and Sarawak
• Advocate and Solicitor, High Court of Malaya

Female, Age 51, Malaysian

Appointed on
20 August 2021

Last re-election on
5 June 2024

Skills Matrix
Accounting & Finance
Corporate Planning & Development

Board Committee(s)
• Chairman of Audit Committee
• Chairman of Board Tender Committee
• Member of Nominating and Remuneration Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Reneuco Berhad
• PT Millennium Pharmacon International Tbk

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Sarah has over 23 years of experience in corporate finance transactions involving equity issuance, mergers and acquisitions, corporate restructuring and corporate valuation. She began her career in investment banking with Malaysian International Merchant Bankers Berhad in 2001 after obtaining her professional qualifications from PricewaterhouseCoopers.

Later in her career, she joined other banking institutions in Malaysia such as Amlnvestment Bank Berhad, Aseambankers Malaysia Berhad (now known as Maybank Investment Bank Berhad) and RHB Investment Bank Berhad.

Presently, Sarah sits as Executive Director of Reneuco Berhad and is also the Executive Director of 3p Capital Advisers Sdn. Bhd., a company licensed with the Securities Commission Malaysia that provides advisory services to the capital market players.

Qualification(s)
• Certified Practising Accountant, CPA Australia
• Capital Markets Services Representative’s License (CMSRL)
• Bachelor of Commerce (Accounting), University of Canberra, Australia

Male, Age 48, Malaysian

Appointed on
10 August 2023

Last re-election on
18 June 2025

Skills Matrix
Accounting & Finance
Corporate Planning & Development

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Affin Bank Berhad

Directorship in public companies
• Boustead Plantations Berhad

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Mohammad Ashraf is the Chief Executive of Lembaga Tabung Angkatan Tentera (LTAT), having been appointed on 1 April 2024. Prior to this, he served as Chief Financial Officer of LTAT from March 2020 to March 2024.

He has over 23 years of experience across Malaysia and Europe, with exposure to corporate finance, investment management and capital markets.

Before joining LTAT, he served as Chief Financial Officer of Ahmad Zaki Resources Berhad from 2017 to 2020. He was previously Associate Director, Corporate Advisory and Structuring at MIDF Amanah Investment Bank Berhad (2015–2016), General Manager, Finance Special Projects at Johawaki Holdings Sdn Bhd (2013–2015), and Associate Director, Capital Market and Corporate Advisory at Prokhas Sdn Bhd (2009–2013).

He began his career at Ernst & Young (Dublin) in 2002 as an Audit Senior and subsequently held roles in Europe with CUNA Mutual Group (Europe) Limited (2005–2007) and UBS Investment Bank (London) (2007–2009).

Qualification(s)
• Chartered Accountant, Malaysian Institute of Accountants
• Member of the Association of Chartered Certified Accountants
• Bachelor of Accountancy (Honours), Universiti Tenaga Nasional

Male, Age 50, Malaysian

Appointed on
1 March 2024

Last re-election on
5 June 2024

Skills Matrix
Accounting & Finance

Board Committee(s)
• Chairman of Board Risk and Investment Committee
• Member of Audit Committee
• Member of Board Tender Committee
• Member of Nominating and Remuneration Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
• Mycron Steel Berhad
• Olympia Industries Bhd

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Dato’ Mohd Zahir has almost 30 years of experience in accounting, finance and asset management. He established his career as an auditor with various accounting firms including PricewaterhouseCoopers and Deloitte & Touche in both of its Malaysia and overseas offices.

He subsequently joined Prasarana Malaysia Berhad (Prasarana) as the Group Chief Financial Officer and was promoted to Chief Executive Officer of Prasarana Integrated Development (PRIDE), a wholly owned subsidiary of Prasarana. Dato’ Mohd Zahir subsequently became the Executive Director of ALFI Advisory PLT and then appointed as Managing Director and Group Chief Executive Officer of Destini Berhad.

Dato’ Mohd Zahir graduated with a Bachelor of Commerce (Accounting) degree from the University of New South Wales, Australia. He attended Oxford Global CEO Programme at Sad Business School, Oxford University, England. He is a Certified Financial Planner, a fellow of the Chartered Accountants Australia & New Zealand and a member of Malaysian Institute of Accountants.

Currently, Dato’ Mohd Zahir sits as an Independent Non-Executive Director of Mycron Steel Berhad and Olympia Industry Berhad.

Qualification(s)
• Certified Financial Planner
• Fellow, Chartered Accountants Australia & New Zealand
• Bachelor of Commerce (Accounting), University of New South Wales, Australia

Female, Age 65, Malaysian

Appointed on
1 March 2024

Last re-election on
5 June 2024

Skills Matrix
Legal & Regulatory
Medical & Pharmaceutical

Board Committee(s)
• Member of Nominating and Remuneration Committee
• Member of Sustainability Committee
• Member of Board Risk and Investment Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Dato’ Dr. Faridah brings to the Board over 37 years of experience in pharmaceutical industry involving pharmacy development, regulatory compliance and drug management.

She started her career with the National Pharmaceutical Control Bureau in 1986 upon graduating with a Bachelor of Pharmacy from the Universiti Sains Malaysia. She has held several important posts in the Government sector, namely at the Ministry of Health, Kuala Lumpur Hospital and the National Pharmaceutical Regulatory Agency. The highest post that she held was the Senior Director for Pharmaceutical Services Programme before her retirement. Upon her departure from the Ministry, she was appointed as an Academic Fellow at the School of Pharmaceutical Sciences, Universiti Sains Malaysia from June 2021 to May 2023.

In addition to her degree and Diploma in Medical Microbiology from the Institute for Medical Research, Dato’ Dr. Faridah received her Master of Science degree in Pharmaceutical Services and Medicines Control from the University of Bradford, United Kingdom. She later pursued and received her Doctor of Philosophy (Ph.D.) in Pharmacoeconomics from Universiti Sains Malaysia in 2006.

Qualification(s)
• Doctor of Philosophy in Pharmacoeconomics, Universiti Sains Malaysia
• Master of Science in Pharmaceutical Services and Medicines Control, University of Bradford, United Kingdom
• Bachelor of Pharmacy (Honours), Universiti Sains Malaysia
• Diploma in Medical Microbiology, Institute for Medical Research, Malaysia

Female, Age 74, Malaysian

Appointed on
19 July 2024

Last re-election on
18 June 2025

Skills Matrix
Medical & Pharmaceutical

Board Committee(s)
• Member of Sustainability Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Professor Emerita Dr. Mary Jane began her career as a Research Assistant under Wellcome Trust Grant at the Dunn School of Pathology, University of Oxford, United Kingdom from 1980 to 1984, while concurrently pursuing her Doctor of Philosophy (PhD) at the same university. She then moved to the Research Institute of the Scripps Clinic in La Jolla, California, United States of America (USA), where she was a Postdoctoral Fellow from January to April 1985.

From 1985 to 1989, Professor Emerita Dr. Mary Jane served as a Lecturer at the School of Medical Sciences at Universiti Sains Malaysia, before moving to the School of Pharmaceutical Sciences, where she held the position of Lecturer from 1990 to 1994. She was subsequently appointed Associate Professor at the School of Pharmaceutical Sciences, Universiti Sains Malaysia, from 1994 to 1995.

In 1995, Professor Emerita Dr. Mary Jane became the Founding Director of the Institute of Health and Community Medicine at Universiti Sarawak Malaysia (UNIMAS), where she served until 2010, establishing the institute and advancing research in public health and community medicine. From 2009 to 2018, Professor Emerita Dr. Mary Jane became the Founder and Chief Scientific Officer at Sentinext Therapeutics Sdn. Bhd., where she played a pivotal role in leading scientific and technological innovations in biotechnology.

Currently, she is the Chief Technical Officer at Integrated Research Associates LLC and the Founder and Director of both MAB Explorations Sdn. Bhd. and Venture Technologies Sdn. Bhd., where she drives cutting-edge research, strategic initiatives, and technological advancements in the field of science and innovation.

Qualification(s)
• Doctor of Philosophy, University of Oxford, United Kingdom
• Master of Arts, Columbia University, New York, USA
• Bachelor of Arts, Princeton University, New Jersey, USA

Male, Age 65, Malaysian

Appointed on
19 July 2024

Last re-election on
18 June 2025

Skills Matrix
Medical & Pharmaceutical

Board Committee(s)
• Member of Audit Committee
• Member of Board Risk and Investment Committee
• Member of Board Tender Committee

Details of any interest in the securities of Pharmaniaga Berhad
• 300,000 ordinary shares

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Dato’ Seri Dr. Hj. Awaludin began his career in the medical field as a Houseman at Hospital Besar Seremban from 1985 to 1986. He then served as a Medical Officer at Hospital Besar Seremban from 1986 to 1987, before moving to Pusat Kesihatan Besar Padang Lebar, Batu Kikir, Negeri Sembilan as a Health Officer from 1987 to 1991. Following this, he worked as a Medical Officer for Tabung Haji in Mekah, Saudi Arabia from 1989 to 1990. In 1991, he transitioned into private practice, becoming a Private Medical Practitioner at Klinik Kita in Ampang, Selangor, where he practiced until 2004. He subsequently served as a Member of the Public Accounts Committee (PAC) of Negeri Sembilan from 2004 to 2013 and from 2018 to 2022.

In his political career, Dato’ Seri Dr. Hj. Awaludin was elected as the Member of the Negeri Sembilan State Legislative Assembly (Wakil Rakyat) for Kota Rembau, serving from 2004 until June 2023. He also served as the Chairman of the Board of Directors of MAINS Zakat Sdn. Bhd. (Pusat Zakat Negeri Sembilan) from 2014 to 2018. From 2013 to 2018, Dato’ Seri Dr. Hj. Awaludin held the position of Speaker of the Negeri Sembilan State Legislative Assembly, playing a key role in the legislative process and governance at the state level.

Qualification(s)
• Bachelor of Medicine, Bachelor of Surgery (MBBS), Universiti Malaya

Male, Age 61, Malaysian

Appointed on
1 September 2025

Last re-election on
None

Skills Matrix
Accounting & Finance

Board Committee(s)
• Member of Audit Committee

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
• Cypark Resources Berhad
• Glomac Berhad

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None Working Experience and Occupations

Datuk Mohd Adzahar brings with him over 37 years of extensive experience in the banking and financial services sector.

He began his career in London as a Trainee Accountant/Auditor at Sagoo & Co after completing his ACCA Level III at Emile Woolf College in 1988. Returning to Malaysia, he joined Bumiputra Merchant Bankers Berhad from 1988 to 1994, advancing to Corporate Banking Manager with responsibilities in corporate lending, syndicated debts, and treasury functions. He later became Corporate Finance Manager at Malaysian Helicopter Berhad, where he played a key role in financing the acquisition of Malaysia Airlines Berhad and managing corporate investments.

In 1995, he transitioned to PMCare Sdn. Bhd. as Chief Executive Officer and Executive Director, where he was instrumental in developing its core operating system and driving the company’s growth in medical management outsourcing. Over the years, he also held board roles in notable companies including Kencana Petroleum Berhad, SapuraKencana Petroleum Berhad, Symphony House Berhad, Edra Global Energy Berhad, and TH Plantations Berhad.

Datuk Mohd Adzahar currently serves as an Independent Non-Executive Director at Cypark Resources Berhad and Glomac Berhad, while also remaining an advisor to SC Healthcare Holdings Sdn. Bhd.. He is also a Fellow of the Association of Chartered Certified Accountants (UK), a member of the Malaysian Institute of Accountants and member of the Certified Financial Planner of Malaysia.

Qualification(s)
• Fellow, Association of Chartered Certified Accountants, United Kingdom
• Member of Malaysian Institute of Accountants
• Member of Financial Planning Association of Malaysia

Male, Age 39, Malaysian

Appointed on
20 May 2024

Last re-election on
Not Applicable

Skills Matrix
Corporate Finance & Operations

Board Committee(s)
None

Details of any interest in the securities of Pharmaniaga Berhad
None

Directorship in other public listed companies
None

Directorship in public companies
None

Any family relationship with Director and/or major shareholder of Pharmaniaga Berhad or any companies that have entered any transactions with Pharmaniaga Berhad or its subsidiaries
None

List of convictions for offences within the past 10 years other than traffic offences, if any
None

Working Experience and Occupations

Firdaus began his career with UEM Edgenta Berhad, where he held roles across Engineering, Operations & Maintenance, Corporate Strategy, Business Development, and Operations Control, gaining broad exposure to operational efficiency, business development, corporate planning, and enterprise performance management.

He subsequently served in the Managing Director’s Office at UEM Edgenta Berhad (Infra Division), before joining UEM Sunrise Berhad as Assistant Manager, Corporate Planning, where he contributed to corporate strategy development, business planning, and operational improvement initiatives.

From 2016 to 2021, Firdaus was Head of Business Development, Group Strategy at Naza Corporation Holdings Sdn. Bhd., leading group-wide strategic initiatives, business development activities, and transformation efforts. He also served as Interim Head of Company at Naza Communications Sdn. Bhd., overseeing operations during a transitional period.

He later joined Capital A Berhad as Senior Manager, Growth & Strategy, where he supported the execution of growth strategies and expansion initiatives.

Firdaus currently serves as Director and Head of Strategic Asset Management at Lembaga Tabung Angkatan Tentera (LTAT). He is responsible for the evaluation, reporting, restructuring, and performance management of LTAT’s strategic investee companies, with a focus on enhancing financial performance, driving sustainable growth, and maximising shareholder value, in alignment with LTAT’s strategic objectives.

Qualification(s)
• Master of Management, Universiti Tun Abdul Razak
• Bachelor of Chemical Engineering, Universiti Putra Malaysia